(Q34415907)

2 August 2017

1 reference

title

Immunodominant CD8 T cell response to Epstein-Barr virus (English)

1 reference

2 August 2017

0 references

Houssaint E

1

1 reference

2 August 2017

Saulquin X

series ordinal

2

1 reference

2 August 2017

Scotet E

series ordinal

3

1 reference

2 August 2017

Bonneville M

series ordinal

4

1 reference

2 August 2017

publication date

1 September 2001

1 reference

Biomedicine and Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

55

1 reference

2 August 2017

issue

7

1 reference

2 August 2017

page(s)

373-380

1 reference

Phenotypic analysis of antigen-specific T lymphocytes

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

EBV persistence in memory B cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Vital involvement of a natural killer cell activation receptor in resistance to viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Clonal Expansions in Acute EBV Infection Are Detectable in the CD8 and not the CD4 Subset and Persist with a Variable CD45 Phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context: evidence for a TAP-independent processing

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900082-8

7 January 2021

10.1016/S0753-3322(01)00082-8

Identifiers

DOI

1 reference

2 August 2017

1 reference